home > drugs a-z list > phentolamine mesylate for injection (phentolamine mesylate) drug center > phentolamine mesylate for injection (phentolamine mesylate) drug - overdosage and contraindications

Acute Toxicity

No deaths due to acute poisoning with phentolamine have been reported.

Oral LD₅₀'s (mg/kg): mice, 1000; rats, 1250.

Signs and Symptoms

Overdosage with phentolamine is characterized chiefly by cardiovascular disturbances, such as arrhythmias, tachycardia, hypotension, and possibly shock. In addition, the following might occur: excitation, headache, sweating, pupillary contraction, visual disturbances; nausea, vomiting, diarrhea; hypoglycemia.

Treatment

There is no specific antidote.

A decrease in blood pressure to dangerous levels or other evidence of shocklike conditions should be treated vigorously and promptly. The patient's legs should be kept raised and a plasma expander should be administered. If necessary, intravenous infusion or norepi-nephrine, titrated to maintain blood pressure at the normotensive level, and all available supportive measures should be included. Epinephrine should not be used, since it may cause a paradoxical reduction in blood pressure.

Myocardial infarction, history of myocardial infarction, coronary insufficiency, angina, or other evidence suggestive of coronary artery disease; hypersensitivity to phentolamine or related compounds.

Last reviewed on RxList: 10/21/2008
This monograph has been modified to include the generic and brand name in many instances.